Skip to content

Meet us at COP31Read more

Matinas BioPharma Holdings Inc Sustainability Reports

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies using its lipid nanocrystal platform delivery technology.

Sector: Manufacturing

Country: United States

Exchange: NYSE American

LEI: 549300TGHXVKQ7EJRO41

7 reports from 2019 to 2025